Mio Tsuruoka

Sendai, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Competing risks of treatment discontinuation of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: March 10, 2026

Clinical Significance of Anti-Atezolizumab Antibodies in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

Clinical Significance of Anti-Atezolizumab Antibodies in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: October 07, 2025

Giant hepatic hemangioma in a Japanese adult patient reduced by sirolimus therapy.

Giant hepatic hemangioma in a Japanese adult patient reduced by sirolimus therapy.

Journal: Clinical journal of gastroenterology

Published: June 07, 2025

Association between deletions in the preS1/2 region of the hepatitis B virus genome and persistently abnormal ALT levels in patients with chronic hepatitis B treated with nucleos(t)ide analogs.

Association between deletions in the preS1/2 region of the hepatitis B virus genome and persistently abnormal ALT levels in patients with chronic hepatitis B treated with nucleos(t)ide analogs.

Journal: Archives of virology

Published: May 06, 2025

Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen.

Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen.

Journal: Cancers

Published: March 20, 2025

A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage.

A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage.

Journal: Cancer medicine

Published: January 24, 2025

Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey.

Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey.

Journal: Journal of gastroenterology

Published: January 14, 2025

The interferon-inducible MxB large GTPase attenuates hepatitis B virus replication by activating the RIG-I innate immunity signaling pathway.

The interferon-inducible MxB large GTPase attenuates hepatitis B virus replication by activating the RIG-I innate immunity signaling pathway.

Journal: Scientific reports

Published: November 15, 2024

Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues.

Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide Analogues.

Journal: Journal of viral hepatitis

Published: November 02, 2024

Identification of low-molecular compounds that inhibit envelope formation of hepatitis B virus.

Identification of low-molecular compounds that inhibit envelope formation of hepatitis B virus.

Journal: Scientific reports

Published: September 10, 2024

Comprehensive analysis of peripheral blood free amino acids in MASLD: the impact of glycine-serine-threonine metabolism.

Comprehensive analysis of peripheral blood free amino acids in MASLD: the impact of glycine-serine-threonine metabolism.

Journal: Amino acids

Published: September 01, 2024

Comparison of hepatitis B virus genotype B and C patients in Japan in terms of family history and maternal age at birth.

Comparison of hepatitis B virus genotype B and C patients in Japan in terms of family history and maternal age at birth.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: August 27, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026